Skip to content
Screener

Illumina ILMN Trading Securities in Marketable Securities

Trading Securities in Marketable Securities at other companies

Agilent Technologies logo
Agilent TechnologiesA
——
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
——

Other financials

Income statement

See full
Revenue$1.2B+9.4%
Gross profit$770.0M+10.8%
Operating income$245.0M+14.5%
Net income$207.0M-11.9%
EPS (diluted)$1.35-9.4%

Balance sheet

See full
Cash & equivalents$1.0B+11.3%
Total debt$1.9B-7.3%
Total equity$2.8B+25.7%
Total assets$6.7B+9.2%

Cash flow

See full
Operating cash flow$201.0M-14.1%
CapEx$39.0M+30.0%
Free cash flow$162.0M-20.6%

Valuation

See full
Market cap$30.18B+95.7%
Enterprise value$31.09B+87.2%
P/E36.6×+24.3×
P/S6.7×+3.1×

Profitability

See full
Gross margin66.4%-0.2pp
Operating margin19.6%—
Net margin18.4%-11.0pp
FCF margin20.7%-3.3pp

Returns & leverage

See full
Return on equity32.4%-35.7pp
Debt / equity0.7×-0.2×
Current ratio1.8×0.0×

Where this comes from

Reported directly by Illumina in its filing.

Tagged under the XBRL concept us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount.

The source filing: Illumina’s 10-Q, filed May 4, 2026.

Filed
May 3, 2026, 8:00 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001110803-26-000092

As of March 29, 2026 and December 28, 2025, non-marketable equity securities, without readily determinable fair values, included in other assets, were $60 million and $58 million, respectively.

Cover / Front Matter

FAQ

What is Illumina's trading securities in marketable securities?
Illumina (ILMN) reported trading securities in marketable securities of $60M in Q1 2026.
How has Illumina's trading securities in marketable securities changed year-over-year?
Illumina's trading securities in marketable securities increased by 30.4% year-over-year, from $46M to $60M.
What is the long-term trend for Illumina's trading securities in marketable securities?
Over 5 years (2020 to 2025), Illumina's trading securities in marketable securities has grown at a -28.7% compound annual growth rate (CAGR), from $314M to $58M.

Ask your AI about Illumina's trading securities in marketable securities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude